Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models
Craig Brooks, … , Sung-Gyu Cho, Zheng Dong
Craig Brooks, … , Sung-Gyu Cho, Zheng Dong
Published April 6, 2009
Citation Information: J Clin Invest. 2009;119(5):1275-1285. https://doi.org/10.1172/JCI37829.
View: Text | PDF
Research Article Nephrology

Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models

  • Text
  • PDF
Abstract

The mechanism of mitochondrial damage, a key contributor to renal tubular cell death during acute kidney injury, remains largely unknown. Here, we have demonstrated a striking morphological change of mitochondria in experimental models of renal ischemia/reperfusion and cisplatin-induced nephrotoxicity. This change contributed to mitochondrial outer membrane permeabilization, release of apoptogenic factors, and consequent apoptosis. Following either ATP depletion or cisplatin treatment of rat renal tubular cells, mitochondrial fragmentation was observed prior to cytochrome c release and apoptosis. This mitochondrial fragmentation was inhibited by Bcl2 but not by caspase inhibitors. Dynamin-related protein 1 (Drp1), a critical mitochondrial fission protein, translocated to mitochondria early during tubular cell injury, and both siRNA knockdown of Drp1 and expression of a dominant-negative Drp1 attenuated mitochondrial fragmentation, cytochrome c release, caspase activation, and apoptosis. Further in vivo analysis revealed that mitochondrial fragmentation also occurred in proximal tubular cells in mice during renal ischemia/reperfusion and cisplatin-induced nephrotoxicity. Notably, both tubular cell apoptosis and acute kidney injury were attenuated by mdivi-1, a newly identified pharmacological inhibitor of Drp1. This study demonstrates a rapid regulation of mitochondrial dynamics during acute kidney injury and identifies mitochondrial fragmentation as what we believe to be a novel mechanism contributing to mitochondrial damage and apoptosis in vivo in mouse models of disease.

Authors

Craig Brooks, Qingqing Wei, Sung-Gyu Cho, Zheng Dong

×

Figure 1

Mitochondrial fragmentation following ATP depletion and cisplatin treatment in RPTCs.

Options: View larger image (or click on image) Download as PowerPoint
Mitochondrial fragmentation following ATP depletion and cisplatin treatm...
RPTCs were transfected with MitoRed to fluorescently label mitochondria. The cells were then incubated with 10 mM azide in glucose-free medium to induce ATP depletion or treated with 20 μM cisplatin in cell culture medium. Mitochondrial morphology in MitoRed-labeled cells was evaluated by fluorescence microscopy to determine the percentage of cells that fragmented mitochondria. Apoptosis was assessed in these cells by cellular and nuclear morphology. (A) Representative images of mitochondrial morphology. Left panel, an untreated control RPTC showing long filamentous mitochondria with a thread-like appearance. Right panel, an azide-treated (3 hours) cell showing shortened punctate mitochondria. Scale bars: 5 μm. (B) Time courses of mitochondrial fragmentation and apoptosis during azide-induced ATP depletion. (C) Time courses of mitochondrial fragmentation and apoptosis during cisplatin incubation. Data in B and C are presented as mean ± SD; n = 3.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts